Subscribe / Renew
July 30, 2014
Biologic drugmaker Amgen said Tuesday that it will lay off 12 to 15 percent of its worldwide workforce and close four sites, even as it reported stellar second-quarter results that trounced Wall Street expectations.
Amgen also raised its forecasts for its 2014 profit and revenue, driving up its shares.
. . .